Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "European Centre for Disease"


19 mentions found


CNN —After a handful of Australian water polo players tested positive for Covid-19 this week, questions have emerged around how the spread of the disease will be mitigated at the Summer Olympic Games in Paris. Five players on Australia’s women’s water polo team have tested positive for Covid-19 as of Wednesday. Although the world is no longer under a public health emergency due to the Covid-19 pandemic, the Olympic Games come as a wave of Covid-19 infections has hit the United States. The French capital is expected to welcome about 15 million tourists while it hosts the Olympic Games. “Attending a mass gathering event increases your chances of being exposed to respiratory diseases, including whooping cough and COVID-19.
Persons: , Lucia Mullen, ” Mullen, Anna Meares, ” Meares, “ We’re, , Joe Biden, Dr, Sanjay Gupta Organizations: CNN, Olympic, Johns Hopkins Center for Health Security, Australian Olympic, US Centers for Disease Control, Paris, CNN Health, Paralympic, WHO, French Ministry of Health, European Centre for Disease Prevention Locations: Paris, , France, Australian, Tokyo, United States, Europe
CNN —Growing up in Texas, Mary Beth Walsh thought she was accustomed to high temperatures. Her hometown of Dallas, which is currently being blasted by unrelenting heat, frequently experiences heat waves. “I always joke around that I have such a high heat tolerance; I bring my sweatshirt with me to class in August (in the US),” she said. Hiking in high temperatures has been a common thread linking recent deaths in the country. Amer Ghazzal/ShutterstockExtreme heat is one consequence of climate change impacting tourist hot spots across Europe.
Persons: Mary Beth Walsh, , , Michael Mosley, we’ve, ” Roo Clark, Stefanos Sidiropoulos, Sidiropoulos, acclimatize, Guglielmo Mangiapane, ” Eduardo Santander, , Amer Ghazzal, Clark, ” Clark, Andrea Ammon, ECDC, Hilary Swift, ” Rebecca Carter, Carter Organizations: CNN, Dallas, , ” Authorities, Tourism Council, Reuters, European Travel Commission, ETC, Santander, European Centre for Disease Prevention, Authorities, Bloomberg, Getty, World Resources Institute Locations: Texas, Athens, Europe, Greece, British, Suffolk, England, Skyros, Canada, Hellas, Italy, Rome, Perugia, Palermo, Rhodes, Czech Republic, Bulgaria, Denmark, Portugal, Spain, Spain’s Seville
A new COVID-19 variant has not been named “ID-10T,” despite claims circulating online. The earliest iteration Reuters could find stems from a satire website. The earliest iteration Reuters could find stems from a now deleted satirical website, ‘Caps Lock News’ published in March 2020 (here). The ‘About’ section of the website reads: “Caps Lock News is a satirical and parody website that should only be used for entertainment purposes” (here). The screenshot stems from a now deleted satire website.
Persons: Bill Gates, Read Organizations: European Centre for Disease, Reuters
James Gathany/CDC/Handout/ReutersWhile serious mosquito-borne diseases remain rare in the US, other countries are not so lucky. While scientists are yet to assess the role climate change has played in the outbreak, Carlson said the links seem clear. But the shift of mosquito-borne diseases into regions like the US and Europe is still likely to be a shock. Scientists are working to develop tools to be able to better assess the link between mosquito-borne diseases and climate change. The path the world takes on reducing planet-heating pollution will lead to very different futures for mosquito-borne diseases, Brady said.
Persons: it’s, Edgar Su, , Oliver Brady, , James Gathany, Colin Carlson, Carlson, I’m, Ernesto Benavides, Celine Gossner, ” Brady, , Shannon LaDeau, they’ve, ” LaDeau, Jon Cherry, Gossner, Brady Organizations: CNN, US Centers for Disease Control, London School of Hygiene, Medicine, Climate Central, Georgetown University, Getty, European Centre for Disease Prevention, Carey Institute of Ecosystems Studies, Louisville Metro Department of Health, Wellness Locations: United States, Singapore, zika, West, Saharan Africa, Peru, Piura, AFP, Europe, , Western Europe, China, Texas , Florida, Hawaii, Arizona, India, Louisville , Kentucky, Florida
There were 71 cases of the disease - which generally causes fever and muscle pain but can be more severe and even sometimes fatal - last year, mainly in France. The health agency warned at a press conference on Thursday there is an increasing risk of a number of mosquito-borne diseases in the European region, including dengue, zika, chikungunya and West Nile virus, linked to the changing climate and the spread of mosquitoes carrying the viruses. “If this continues, we can expect to see more cases and possibly deaths from diseases such as dengue, chikungunya and West Nile fever," said Andrea Ammon, ECDC director. Aedes aegypti, which spreads diseases including dengue, yellow fever and chikungunya, became established in Cyprus last year and could make further inroads, it said. While the rates of some mosquito-borne diseases in Europe have not risen dramatically in recent years or even fallen slightly, such as malaria and zika, others have seen a "striking" rise, particularly dengue, the ECDC said.
Persons: Andrea Ammon, Aedes, Jennifer Rigby, Jane Merriman Organizations: European Centre for Disease Prevention, World Health Organization, El, Thomson Locations: Europe, France, chikungunya, West, Cyprus, Peru, El Nino
The company — which has its COVID-19 vaccine as the only marketed product after 35 years in business — on Tuesday flagged significant uncertainty around its 2023 revenue, funding from the U.S. government, and pending arbitration with global vaccine alliance Gavi. Syringes with needles are seen in front of a displayed Novavax logo in this illustration taken, November 27, 2021. Novavax faces near-term risks as protein-based vaccines take longer to produce than mRNA-based competitors, Novavax CEO John Jacobs has said. "While there is the potential for a substantial booster market ... we don't expect Novavax to be a major player in the booster opportunity." As of last close, Novavax's U.S.-listed shares were down 97% from their February 2021 record high of $331.68.
The stock had dropped 26.2% to $6.83 around 8:55 ET (13:55 GMT), while its Frankfurt-listed shares slumped more than 27%. The company - whose COVID vaccine is its only marketed product after 35 years in business - on Tuesday flagged significant uncertainty around its 2023 revenue, funding from the U.S. government, and pending arbitration with global vaccine alliance Gavi. Syringes with needles are seen in front of a displayed Novavax logo in this illustration taken, November 27, 2021. Novavax faces near-term risks as protein-based vaccines take longer to produce than mRNA-based competitors, Novavax CEO John Jacobs has said. As of last close, Novavax's U.S.-listed shares are down 97% from their February 2021 record high of $331.68.
EU regulator expects eventually to introduce annual COVID shots
  + stars: | 2023-02-15 | by ( ) www.reuters.com   time to read: +1 min
LONDON, Feb 15 (Reuters) - The European Medicines Agency (EMA) expects COVID vaccination campaigns to be conducted once a year, similar to the approach with flu inoculation, it said on Wednesday. In Europe, there is a marked decline in new COVID cases, hospitalisations and deaths - the lowest levels observed in the European Union in the past twelve months, he said, citing data from the European Centre for Disease Prevention and Control (ECDC). Still, the virus continues to evolve, and an organised approach is needed to maintain the range of vaccines to confer an adequate breadth of protection to emerging variants, he said. The EMA is currently in discussions with the World Health Organization and other regulatory agencies about the criteria and process that will lead to the potential update of the vaccines in view of future vaccination campaigns, he added. Reporting by Natalie Grover in London Editing by David Goodman and Jane MerrimanOur Standards: The Thomson Reuters Trust Principles.
China plans to ease travel restrictions on Jan 8, despite a wave of new infections which has left Chinese hospitals and funeral houses overwhelmed. The IPCR also recommended that all passengers on flights to and from China should wear face masks, that EU governments introduce random testing of passengers arriving from China and that they test and sequence wastewater in airports with international flights and planes arriving from China. "The Member States agree to assess the situation and review the introduced measures by mid-January 2023," the IPCR said in statement. The European Centre for Disease Control (ECDC) said last week it did not currently recommend measures on travellers from China, because the variants circulating in China were already in the European Union. The ECDC also said EU citizens had relatively high vaccination levels and the potential for imported infections was low compared to daily infections in the EU, with healthcare systems currently coping.
BRUSSELS, Jan 3 (Reuters) - Most European Union countries favour introducing pre-departure COVID testing for travellers from China, the European Commission said on Tuesday, as Beijing plans to lift travel restrictions on its citizens despite a wave of COVID infections. The common EU approach emerged after a meeting on Tuesday of the Health Security Committee, an EU advisory body of national health experts from the EU-s 27 countries and chaired by the Commission. "The overwhelming majority of countries are in favour of pre-departure testing," a Commission spokesman said. The spokesman said all EU countries agreed they needed a coordinated approach to the changing situation in China and to deal with implications of increased travel from China to Europe after China lifts its stringent pandemic polices on Jan 8th. The European Centre for Disease Prevention and Control said last week it did not currently recommend measures on travellers from China.
BRUSSELS, Jan 2 (Reuters) - European Union government health officials will hold talks on Wednesday on a coordinated response to the surge in COVID-19 infections in China, the Swedish EU presidency said on Monday, after December talks concluded with no decisions on the matter. At a similar meeting on Dec. 29, held online among over 100 representatives from EU governments, EU health agencies and the World Health Organisation, Italy urged the rest of the EU to follow its lead and test travellers from China for COVID, with Beijing poised to lift travel restrictions on Jan. 8. "There is a scheduled Integrated Political Crisis Response meeting on Wednesday, January 4, for an update of the COVID-19 situation in China and to discuss possible EU measures to be taken in a coordinated way," a spokeswoman for the Swedish presidency of the EU said. Kyriakides said the bloc should be "very vigilant" as reliable epidemiological and testing data for China were scarce, advising EU health ministers to assess their current practices on genomic sequencing of the coronavirus "as an immediate step". The European Centre for Disease Prevention and Control said last week it did not currently recommend measures on travellers from China.
The commissioner's letter, dated Dec. 29, followed an online meeting of over 100 representatives from EU members, EU health agencies and the World Health Organisation to discuss how to deal with the outbreak in China. Italy has urged the rest of the European Union to follow its lead and test travellers from China, but most EU members have said they saw no need to do so. Kyriakides said some EU members had proposed measures such as the random testing of travellers. The European Centre for Disease Prevention and Control says it does not currently recommend measures on travellers from China. It said the variants circulating in China were already in the European Union, EU citizens had relatively high vaccination levels and the potential imported infections were low compared to the number of daily infections in the EU, with health care systems currently coping.
This winter, health officials have warned of what has been dubbed a tripledemic of influenza, RSV and continued COVID-19 cases, adding to the pressure on over-burdened health services. In Wales, for instance, there were 111.6 confirmed RSV cases per 100,000 in children aged under five in the week ending Nov. 27. In the week ended Dec 18, European cases rose 7% over the week prior, according to ECDC figures. But scientists are concerned that social interaction during the festive season could lead to further increases in respiratory infections, especially as people meet vulnerable elderly relatives. As an added complication, viral respiratory infections can predispose patients to bacterial infections, just when some common antibiotics that can treat them are in short supply in Europe.
Hendrik Schmidt/Pool via Reuters/File PhotoLONDON, Nov 30 (Reuters) - The number of people in Europe with undiagnosed HIV has risen as testing rates fell during the COVID-19 pandemic, threatening a global goal of ending the disease by 2030, a report said. This region includes Russia and Ukraine, which have the area's highest rates of HIV infection. This setback was likely because services related to HIV, including testing, were sidelined in many European countries during the two years of the pandemic, the report found. The report used modelling to predict the number of estimated infections and compared that to testing data provided by 46 of the 53 countries in the WHO's European region. An estimated one in eight people living with HIV in that region remains undiagnosed, it found.
Data showed that in Europe last year, reported cases of the Acinetobacter bacteria group more than doubled compared with pre-pandemic annual numbers. Some scientists link the rise in hospital-acquired superbug infections during the pandemic to wider antibiotic prescriptions to treat COVID-19 and other bacterial infections during long hospital stays. He also said the data showed decreases in cases of some other common superbugs in European hospitals. The European report is consistent with a trend noted last year in the United States, where government data showed that U.S. deaths from drug-resistant infections jumped 15% in 2020. Experts call superbug infections, including fungal pathogens, a silent pandemic that causes more than a million deaths annually but does not draw attendant focus or funding for research.
COVID variants BQ.1/BQ.1.1 make up 35% of U.S. cases
  + stars: | 2022-11-04 | by ( ) www.reuters.com   time to read: +2 min
The subvariants made up nearly 9% of total cases in the week of Oct. 15 and their proportion has been rising steadily among circulating cases since then. New variants are monitored closely by regulators and vaccine manufacturers in case they start to evade protection offered by current shots. BQ.1.1 made up nearly 19% of circulating variants and BQ.1 was estimated to make up 16.5% of circulating cases in the week of Nov. 5, the U.S. CDC said on Friday. The BA.5 subvariant, which drove up cases earlier this year, is estimated to make up about 39% of cases, compared with nearly 51% in the week ended Oct. 29. Coronavirus cases saw a small uptick for the week ended Nov. 2, data from CDC showed.
REUTERS/Dado Ruvic/Illustration/File PhotoOct 21 (Reuters) - U.S. health regulators on Friday estimated that BQ.1 and closely related BQ.1.1 accounted for 16.6% of coronavirus variants in the country, nearly doubling from last week, while Europe expects them to become the dominant variants in a month. The two variants are descendants of Omicron's BA.5 subvariant, which is the dominant form of the coronavirus in the United States. New variants are monitored closely by regulators and vaccine manufacturers in case they start to evade protection offered by current shots. The World Health Organization this week said BQ.1.1 is circulating in at least 29 countries. The U.S. CDC said on Friday BQ.1 and BQ.1.1 last week were estimated to make up 9.4% of circulating variants.
Europe likely entering another COVID wave, says WHO and ECDC
  + stars: | 2022-10-12 | by ( ) www.reuters.com   time to read: +1 min
Oct 12 (Reuters) - Another wave of COVID-19 infections may have begun in Europe as cases begin to tick up across the region, the World Health Organization and European Centre for Disease Prevention and Control (ECDC) said on Wednesday. "We are unfortunately seeing indicators rising again in Europe, suggesting that another wave of infections has begun." Public health experts have warned that vaccine fatigue and confusion over available vaccines will likely limit booster uptake in the region. read moreMillions of people across Europe remain unvaccinated against COVID-19, the WHO and ECDC noted. They urged European countries to administer both flu and COVID-19 vaccines ahead of an expected surge in cases of seasonal influenza.
Social media users are sharing a 45-second clip from a British news channel’s report which juxtaposes European COVID-19 vaccination rates and a single month of mortality rates to imply that countries with higher COVID-19 vaccination will have greater “excess mortality”. However, no “study” has reached the conclusion that European national vaccination rates correlate with mortality, as suggested in some social media posts. The map depicts so-called excess mortality rates across Europe in June 2022, which is the excess of deaths that month as compared to the average rate in the same month during the baseline period 2016-2019. “You really can’t draw valid conclusions on a single factor, like vaccination rates from country-level aggregated data, since countries differ in many ways other than vaccination. The clip selectively compares unrelated European datasets to suggest that high national rates of COVID-19 vaccination led to high excess mortality.
Total: 19